Total Payments
$1,833
2024 Payments
$270.31
Companies
17
Transactions
35
Medicare Patients
4,874
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$1,833 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,833 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $372.71 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $305.42 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $261.40 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $139.67 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $133.22 | 2 | $0 (2019) |
| The Medicines Company | $124.48 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $122.29 | 1 | $0 (2024) |
| Allergan Inc. | $120.90 | 2 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $48.64 | 2 | $0 (2020) |
| Harmony Biosciences LLC | $43.28 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.31 | 3 | La Jolla Pharmaceutical Company ($125.85) |
| 2023 | $287.63 | 4 | Merck Sharp & Dohme LLC ($125.00) |
| 2022 | $80.11 | 3 | Harmony Biosciences LLC ($43.28) |
| 2021 | $155.53 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($119.85) |
| 2020 | $67.92 | 3 | Mallinckrodt Hospital Products Inc. ($32.33) |
| 2019 | $415.67 | 6 | Merck Sharp & Dohme Corporation ($136.40) |
| 2018 | $296.85 | 5 | La Jolla Pharmaceutical Company ($125.00) |
| 2017 | $258.54 | 8 | The Medicines Company ($124.48) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $125.85 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $122.29 | General |
| Category: COVID-19 | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/23/2023 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/09/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: HFCWO | ||||||
| 10/25/2022 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| Category: HFCWO | ||||||
| 04/20/2022 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 03/07/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $43.28 | General |
| Category: Neurological Disorders | ||||||
| 10/15/2021 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Vaccines | ||||||
| 09/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $119.85 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2021 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/21/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 02/14/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Respiratory | ||||||
| 11/21/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $119.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/08/2019 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Immunology | ||||||
| 07/18/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $121.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GIAPREZA | ||||||
| 03/15/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $109.10 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/28/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,106 | 3,468 | $1.2M | $435,247 |
| 2022 | 8 | 1,078 | 3,399 | $835,970 | $431,988 |
| 2021 | 11 | 980 | 3,268 | $890,215 | $406,942 |
| 2020 | 9 | 1,710 | 4,420 | $1.1M | $542,163 |
Total Patients
4,874
Total Services
14,555
Medicare Billing
$1.8M
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 279 | 1,454 | $803,560 | $256,796 | 32.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 283 | 944 | $217,515 | $93,644 | 43.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 277 | 779 | $125,380 | $51,471 | 41.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 125 | 132 | $47,680 | $19,180 | 40.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 60 | 71 | $16,680 | $6,300 | 37.8% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 29 | 32 | $9,245 | $3,676 | 39.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 20 | 21 | $5,580 | $2,260 | 40.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 19 | 20 | $3,395 | $1,377 | 40.6% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 14 | 15 | $1,400 | $544.50 | 38.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 260 | 1,285 | $462,600 | $238,948 | 51.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 340 | 1,349 | $229,330 | $118,948 | 51.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 177 | 194 | $64,020 | $33,019 | 51.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 163 | 401 | $48,120 | $24,487 | 50.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 82 | 110 | $19,800 | $10,315 | 52.1% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 24 | 26 | $5,980 | $3,131 | 52.4% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 17 | 17 | $3,740 | $1,908 | 51.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 15 | 17 | $2,380 | $1,231 | 51.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 242 | 1,181 | $525,545 | $218,156 | 41.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 278 | 1,445 | $238,425 | $127,522 | 53.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 148 | 158 | $51,350 | $24,337 | 47.4% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 108 | 153 | $29,835 | $14,354 | 48.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 206 | $23,690 | $12,512 | 52.8% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 33 | 33 | $5,940 | $4,026 | 67.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 25 | $3,500 | $2,054 | 58.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 21 | 22 | $5,390 | $1,252 | 23.2% |
About Dr. Rajiv Philip, MD
Dr. Rajiv Philip, MD is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063601045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajiv Philip, MD has received a total of $1,833 in payments from pharmaceutical and medical device companies, with $270.31 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,833).
As a Medicare-enrolled provider, Philip has provided services to 4,874 Medicare beneficiaries, totaling 14,555 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Pasadena, CA
- Active Since 10/16/2007
- Last Updated 07/22/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1063601045
Products in Payments
- GIAPREZA (Drug) $372.71
- OFEV (Drug) $283.67
- ZERBAXA (Drug) $136.40
- RECARBRIO (Drug) $125.00
- ORBACTIV (Drug) $124.48
- Veklury (Drug) $122.29
- BRILINTA (Drug) $121.05
- AVYCAZ (Drug) $120.90
- ANORO (Drug) $100.55
- LifeVest (Device) $48.64
- Wakix (Drug) $43.28
- SMARTVEST (Device) $38.72
- ACTHAR (Biological) $32.33
- Xolair (Biological) $23.01
- NUCALA (Biological) $22.17
- STIOLTO RESPIMAT (Drug) $21.75
- SUNOSI (Drug) $19.98
- VIBATIV (Drug) $17.13
- ANORO ELLIPTA (Drug) $16.95
- Fluad Quadrivalent (Biological) $15.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882